$DGX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in QUEST DIAGNOSTICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in QUEST DIAGNOSTICS INC. Get notifications about new insider transactions in QUEST DIAGNOSTICS INC for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 18 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 19 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 40.43 | 62,079 | 2,509,699 | 9,921 | |
Jun 19 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 62.46 | 9,921 | 619,684 | 45,191 | 55.1 K to 45.2 K (-18.00 %) |
Jun 19 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 62.65 | 116,746 | 7,314,487 | 55,049 | 171.8 K to 55 K (-67.96 %) |
Jun 19 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 40.43 | 9,921 | 401,081 | 171,795 | 161.9 K to 171.8 K (+6.13 %) |
Jun 19 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 52.25 | 54,667 | 2,856,077 | 161,874 | 107.2 K to 161.9 K (+50.99 %) |
Jun 19 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 40.43 | 62,079 | 2,509,699 | 107,207 | 45.1 K to 107.2 K (+137.56 %) |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | M | 44.19 | 620 | 27,395 | 0 | |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | M | 42.42 | 742 | 31,472 | 0 | |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | M | 49.04 | 10,000 | 490,400 | 0 | |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | M | 42.63 | 20,000 | 852,500 | 0 | |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | A | 61.23 | 6,111 | 374,146 | 6,111 | |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Sell | S | 62.00 | 31,362 | 1,944,444 | 17,829 | 49.2 K to 17.8 K (-63.76 %) |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Buy | M | 44.19 | 620 | 27,395 | 49,191 | 48.6 K to 49.2 K (+1.28 %) |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Buy | M | 42.42 | 742 | 31,472 | 48,571 | 47.8 K to 48.6 K (+1.55 %) |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Buy | M | 49.04 | 10,000 | 490,400 | 47,829 | 37.8 K to 47.8 K (+26.43 %) |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Buy | M | 42.63 | 20,000 | 852,500 | 37,829 | 17.8 K to 37.8 K (+112.18 %) |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Grant | A | 0.00 | 1,975 | 0 | 17,829 | 15.9 K to 17.8 K (+12.46 %) |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Option Exercise | A | 61.23 | 6,111 | 374,146 | 6,111 | |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Grant | A | 0.00 | 1,975 | 0 | 15,927 | 14 K to 15.9 K (+14.16 %) |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 61.23 | 6,111 | 374,146 | 6,111 | |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Grant | A | 0.00 | 1,975 | 0 | 4,773 | 2.8 K to 4.8 K (+70.59 %) |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | A | 61.23 | 5,706 | 349,350 | 5,706 | |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | A | 61.23 | 6,111 | 374,146 | 6,111 | |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Grant | A | 0.00 | 1,975 | 0 | 22,151 | 20.2 K to 22.2 K (+9.79 %) |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Option Exercise | A | 61.23 | 6,111 | 374,146 | 6,111 | |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Grant | A | 0.00 | 1,975 | 0 | 15,927 | 14 K to 15.9 K (+14.16 %) |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | BUEHLER WILLIAM F | Director | Option Exercise | A | 61.23 | 6,111 | 374,146 | 6,111 | |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | BUEHLER WILLIAM F | Director | Grant | A | 0.00 | 1,975 | 0 | 26,225 | 24.3 K to 26.2 K (+8.14 %) |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Option Exercise | A | 61.23 | 6,111 | 374,146 | 6,111 | |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Grant | A | 0.00 | 1,975 | 0 | 16,427 | 14.5 K to 16.4 K (+13.67 %) |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Option Exercise | A | 61.23 | 6,111 | 374,146 | 6,111 | |
May 23 2013 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Grant | A | 0.00 | 1,975 | 0 | 10,609 | 8.6 K to 10.6 K (+22.87 %) |
May 17 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 59.91 | 276 | 16,534 | 72,079 | 72.4 K to 72.1 K (-0.38 %) |
May 15 2013 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Sell | S | 59.41 | 1,214 | 72,122 | 8,634 | 9.8 K to 8.6 K (-12.33 %) |
May 03 2013 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Option Exercise | M | 55.40 | 10,000 | 554,000 | 0 | |
May 03 2013 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Sell | S | 57.20 | 10,000 | 572,008 | 13,952 | 24 K to 14 K (-41.75 %) |
May 03 2013 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Buy | M | 55.40 | 10,000 | 554,000 | 23,952 | 14 K to 24 K (+71.67 %) |
May 03 2013 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | President and CEO | Payment of Exercise | F | 56.69 | 2,721 | 154,253 | 91,580 | 94.3 K to 91.6 K (-2.89 %) |
Apr 17 2013 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | President and CEO | Payment of Exercise | F | 58.96 | 4,725 | 278,586 | 94,116 | 98.8 K to 94.1 K (-4.78 %) |
Apr 12 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | M | 41.32 | 592 | 24,461 | 0 | |
Apr 12 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | M | 36.60 | 878 | 32,130 | 0 | |
Apr 12 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Sell | S | 58.35 | 1,470 | 85,775 | 15,854 | 17.3 K to 15.9 K (-8.49 %) |
Apr 12 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Buy | M | 41.32 | 592 | 24,461 | 17,324 | 16.7 K to 17.3 K (+3.54 %) |
Apr 12 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Buy | M | 36.60 | 878 | 32,130 | 16,732 | 15.9 K to 16.7 K (+5.54 %) |
Apr 02 2013 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 56.25 | 1,159 | 65,194 | 1,159 | |
Apr 02 2013 | DGX | QUEST DIAGNOSTICS ... | ORDONEZ KATHY | SVP, Diagnostic Sol ... | Payment of Exercise | F | 56.23 | 245 | 13,775 | 9,569 | 9.8 K to 9.6 K (-2.50 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | President and CEO | Payment of Exercise | F | 56.35 | 1,588 | 89,476 | 98,591 | 100.2 K to 98.6 K (-1.59 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | President and CEO | Grant | A | 0.00 | 3,359 | 0 | 100,011 | 96.7 K to 100 K (+3.48 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 56.45 | 1,972 | 111,328 | 45,128 | 47.1 K to 45.1 K (-4.19 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 56.83 | 20 | 1,137 | 47,100 | 47.1 K to 47.1 K (-0.04 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 56.35 | 1,183 | 66,656 | 47,120 | 48.3 K to 47.1 K (-2.45 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Grant | A | 0.00 | 3,175 | 0 | 48,303 | 45.1 K to 48.3 K (+7.04 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Payment of Exercise | F | 56.35 | 3,084 | 173,768 | 126,722 | 129.8 K to 126.7 K (-2.38 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Grant | A | 0.00 | 6,525 | 0 | 129,806 | 123.3 K to 129.8 K (+5.29 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 56.35 | 934 | 52,626 | 72,146 | 73.1 K to 72.1 K (-1.28 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Grant | A | 0.00 | 2,505 | 0 | 73,080 | 70.6 K to 73.1 K (+3.55 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Payment of Exercise | F | 56.35 | 2,001 | 112,746 | 54,232 | 56.2 K to 54.2 K (-3.56 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Grant | A | 0.00 | 4,233 | 0 | 56,233 | 52 K to 56.2 K (+8.14 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Payment of Exercise | F | 56.35 | 395 | 22,256 | 12,770 | 13.2 K to 12.8 K (-3.00 %) |
Mar 07 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Grant | A | 0.00 | 1,059 | 0 | 13,165 | 12.1 K to 13.2 K (+8.75 %) |
Mar 06 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 56.64 | 778 | 44,063 | 45,128 | 45.9 K to 45.1 K (-1.69 %) |
Mar 06 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 55.97 | 463 | 25,914 | 45,898 | 46.4 K to 45.9 K (-1.00 %) |
Mar 06 2013 | DGX | QUEST DIAGNOSTICS ... | ORDONEZ KATHY | SVP, Diagnostic Sol ... | Payment of Exercise | F | 55.97 | 364 | 20,373 | 9,814 | 10.2 K to 9.8 K (-3.58 %) |
Mar 06 2013 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Payment of Exercise | F | 55.97 | 1,182 | 66,157 | 123,281 | 124.5 K to 123.3 K (-0.95 %) |
Mar 06 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 55.97 | 661 | 36,996 | 70,575 | 71.2 K to 70.6 K (-0.93 %) |
Mar 06 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Payment of Exercise | F | 55.97 | 171 | 9,571 | 12,106 | 12.3 K to 12.1 K (-1.39 %) |
Mar 06 2013 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Payment of Exercise | F | 55.97 | 617 | 34,533 | 52,000 | 52.6 K to 52 K (-1.17 %) |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | President and CEO | Option Exercise | A | 56.12 | 168,490 | 9,455,659 | 168,490 | |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | President and CEO | Grant | A | 0.00 | 27,176 | 0 | 96,652 | 69.5 K to 96.7 K (+39.12 %) |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | Haydon John B. | SVP, Operations | Option Exercise | A | 56.12 | 44,009 | 2,469,785 | 44,009 | |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | Haydon John B. | SVP, Operations | Grant | A | 0.00 | 7,099 | 0 | 23,099 | 16 K to 23.1 K (+44.37 %) |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Option Exercise | A | 56.12 | 44,009 | 2,469,785 | 44,009 | |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | Cunningham Everett | SVP, Commercial | Grant | A | 0.00 | 7,099 | 0 | 20,045 | 12.9 K to 20 K (+54.84 %) |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | A | 56.12 | 32,693 | 1,834,731 | 32,693 | |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Grant | A | 0.00 | 5,274 | 0 | 46,361 | 41.1 K to 46.4 K (+12.84 %) |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Option Exercise | A | 56.12 | 57,840 | 3,245,981 | 57,840 | |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Grant | A | 0.00 | 9,330 | 0 | 124,463 | 115.1 K to 124.5 K (+8.10 %) |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Option Exercise | A | 56.12 | 12,071 | 677,425 | 12,071 | |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Grant | A | 0.00 | 1,947 | 0 | 12,245 | 10.3 K to 12.2 K (+18.91 %) |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Option Exercise | A | 56.12 | 44,009 | 2,469,785 | 44,009 | |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Grant | A | 0.00 | 7,099 | 0 | 52,533 | 45.4 K to 52.5 K (+15.62 %) |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Option Exercise | A | 56.12 | 44,009 | 2,469,785 | 44,009 | |
Feb 27 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Grant | A | 0.00 | 7,099 | 0 | 71,232 | 64.1 K to 71.2 K (+11.07 %) |
Feb 22 2013 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Sell | S | 57.42 | 2,000 | 114,840 | 15,854 | 17.9 K to 15.9 K (-11.20 %) |
Feb 22 2013 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Option Exercise | M | 55.40 | 10,000 | 554,000 | 0 | |
Feb 22 2013 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Sell | S | 57.30 | 10,000 | 572,957 | 14,452 | 24.5 K to 14.5 K (-40.90 %) |
Feb 22 2013 | DGX | QUEST DIAGNOSTICS ... | BRITELL JENNE K | Director | Buy | M | 55.40 | 10,000 | 554,000 | 24,452 | 14.5 K to 24.5 K (+69.19 %) |
Feb 19 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 57.53 | 1,442 | 82,961 | 41,087 | 42.5 K to 41.1 K (-3.39 %) |
Feb 19 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 56.97 | 857 | 48,823 | 42,529 | 43.4 K to 42.5 K (-1.98 %) |
Feb 19 2013 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Payment of Exercise | F | 56.97 | 1,761 | 100,324 | 115,133 | 116.9 K to 115.1 K (-1.51 %) |
Feb 19 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Payment of Exercise | F | 56.97 | 279 | 15,895 | 10,298 | 10.6 K to 10.3 K (-2.64 %) |
Feb 19 2013 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Payment of Exercise | F | 56.97 | 1,142 | 65,060 | 45,434 | 46.6 K to 45.4 K (-2.45 %) |
Feb 19 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 56.97 | 712 | 40,563 | 64,133 | 64.8 K to 64.1 K (-1.10 %) |
Feb 12 2013 | DGX | QUEST DIAGNOSTICS ... | Cohen Jon R | SVP and Chief Medic ... | Payment of Exercise | F | 58.45 | 2,426 | 141,800 | 46,576 | 49 K to 46.6 K (-4.95 %) |
Feb 12 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 57.48 | 3,481 | 200,074 | 43,386 | 46.9 K to 43.4 K (-7.43 %) |
Feb 12 2013 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Payment of Exercise | F | 58.45 | 1,358 | 79,375 | 46,867 | 48.2 K to 46.9 K (-2.82 %) |
Feb 12 2013 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Clinical Franc ... | Payment of Exercise | F | 58.45 | 1,453 | 84,928 | 64,845 | 66.3 K to 64.8 K (-2.19 %) |
Feb 12 2013 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Payment of Exercise | F | 58.45 | 3,726 | 217,785 | 116,894 | 120.6 K to 116.9 K (-3.09 %) |
Feb 12 2013 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Payment of Exercise | F | 58.45 | 662 | 38,694 | 10,577 | 11.2 K to 10.6 K (-5.89 %) |
Jan 18 2013 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Option Exercise | M | 55.40 | 10,000 | 554,000 | 0 | |
Jan 18 2013 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Sell | S | 60.00 | 10,000 | 600,000 | 13,952 | 24 K to 14 K (-41.75 %) |
Jan 18 2013 | DGX | QUEST DIAGNOSTICS ... | PFEIFFER GARY M | Director | Buy | M | 55.40 | 10,000 | 554,000 | 23,952 | 14 K to 24 K (+71.67 %) |
Jan 03 2013 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 58.69 | 990 | 58,098 | 990 | |
Jan 02 2013 | DGX | QUEST DIAGNOSTICS ... | ORDONEZ KATHY | SVP, Discovery & De ... | Payment of Exercise | F | 58.25 | 239 | 13,921 | 10,166 | 10.4 K to 10.2 K (-2.30 %) |
Oct 05 2012 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Option Exercise | M | 40.43 | 46,667 | 1,886,630 | 46,667 | |
Oct 05 2012 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Sell | S | 64.00 | 46,667 | 2,986,688 | 154,603 | 201.3 K to 154.6 K (-23.19 %) |
Oct 05 2012 | DGX | QUEST DIAGNOSTICS ... | HAGEMANN ROBERT | SVP & Chief Financi ... | Buy | M | 40.43 | 46,667 | 1,886,630 | 201,233 | 154.6 K to 201.2 K (+30.19 %) |
Oct 02 2012 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 63.42 | 779 | 49,404 | 779 | |
Oct 02 2012 | DGX | QUEST DIAGNOSTICS ... | ORDONEZ KATHY | SVP, Discovery & De ... | Payment of Exercise | F | 63.19 | 239 | 15,101 | 10,400 | 10.6 K to 10.4 K (-2.25 %) |
Sep 07 2012 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Option Exercise | M | 55.40 | 10,000 | 554,000 | 0 | |
Sep 07 2012 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Sell | S | 62.32 | 10,000 | 623,192 | 17,854 | 27.9 K to 17.9 K (-35.90 %) |
Sep 07 2012 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Buy | M | 55.40 | 10,000 | 554,000 | 27,854 | 17.9 K to 27.9 K (+56.01 %) |
Aug 16 2012 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Option Exercise | M | 30.46 | 20,000 | 609,100 | 0 | |
Aug 16 2012 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Sell | S | 59.24 | 20,000 | 1,184,718 | 13,952 | 34 K to 14 K (-58.91 %) |
Aug 16 2012 | DGX | QUEST DIAGNOSTICS ... | WILENSKY GAIL R | Director | Buy | M | 30.46 | 20,000 | 609,100 | 33,952 | 14 K to 34 K (+143.35 %) |
Aug 14 2012 | DGX | QUEST DIAGNOSTICS ... | BUEHLER WILLIAM F | Director | Option Exercise | M | 30.46 | 20,000 | 609,100 | 0 | |
Aug 14 2012 | DGX | QUEST DIAGNOSTICS ... | BUEHLER WILLIAM F | Director | Option Exercise | M | 55.40 | 10,000 | 554,000 | 0 | |
Aug 14 2012 | DGX | QUEST DIAGNOSTICS ... | BUEHLER WILLIAM F | Director | Sell | S | 59.34 | 20,000 | 1,186,804 | 24,250 | 44.3 K to 24.3 K (-45.20 %) |
Aug 14 2012 | DGX | QUEST DIAGNOSTICS ... | BUEHLER WILLIAM F | Director | Buy | M | 30.46 | 20,000 | 609,100 | 44,250 | 24.3 K to 44.3 K (+82.47 %) |
Aug 14 2012 | DGX | QUEST DIAGNOSTICS ... | BUEHLER WILLIAM F | Director | Sell | S | 59.24 | 10,000 | 592,360 | 24,250 | 34.3 K to 24.3 K (-29.20 %) |
Aug 14 2012 | DGX | QUEST DIAGNOSTICS ... | BUEHLER WILLIAM F | Director | Buy | M | 55.40 | 10,000 | 554,000 | 34,250 | 24.3 K to 34.3 K (+41.24 %) |
Aug 09 2012 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Option Exercise | M | 52.24 | 40,000 | 2,089,400 | 0 | |
Aug 09 2012 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Sell | S | 60.11 | 40,000 | 2,404,324 | 66,016 | 106 K to 66 K (-37.73 %) |
Aug 09 2012 | DGX | QUEST DIAGNOSTICS ... | Doherty Catherine T. | SVP, Physician Serv ... | Buy | M | 52.24 | 40,000 | 2,089,400 | 105,914 | 65.9 K to 105.9 K (+60.69 %) |
Aug 09 2012 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Option Exercise | M | 55.40 | 10,000 | 554,000 | 0 | |
Aug 09 2012 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Sell | S | 59.98 | 1,770 | 106,165 | 9,848 | 11.6 K to 9.8 K (-15.23 %) |
Aug 09 2012 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Sell | S | 60.00 | 10,000 | 600,000 | 11,618 | 21.6 K to 11.6 K (-46.26 %) |
Aug 09 2012 | DGX | QUEST DIAGNOSTICS ... | BALDWIN JOHN C MD | Director | Buy | M | 55.40 | 10,000 | 554,000 | 21,618 | 11.6 K to 21.6 K (+86.07 %) |
Aug 07 2012 | DGX | QUEST DIAGNOSTICS ... | RUSCKOWSKI STEPHEN H | President and CEO | Buy | P | 59.34 | 5,000 | 296,677 | 68,034 | 63 K to 68 K (+7.93 %) |
Aug 02 2012 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 52.24 | 54,667 | 2,855,531 | 0 | |
Aug 02 2012 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 24.76 | 31,778 | 786,823 | 0 | |
Aug 02 2012 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 24.76 | 11,408 | 282,462 | 31,778 | |
Aug 02 2012 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Option Exercise | M | 24.76 | 28,814 | 713,435 | 43,186 | |
Aug 02 2012 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 58.68 | 86,445 | 5,072,299 | 48,111 | 134.6 K to 48.1 K (-64.24 %) |
Aug 02 2012 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 52.24 | 54,667 | 2,855,531 | 134,474 | 79.8 K to 134.5 K (+68.50 %) |
Aug 02 2012 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 24.76 | 31,778 | 786,823 | 79,807 | 48 K to 79.8 K (+66.16 %) |
Aug 02 2012 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 24.76 | 11,408 | 282,462 | 48,029 | 36.6 K to 48 K (+31.15 %) |
Aug 02 2012 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Sell | S | 58.59 | 28,814 | 1,688,270 | 36,621 | 65.4 K to 36.6 K (-44.03 %) |
Aug 02 2012 | DGX | QUEST DIAGNOSTICS ... | PREVOZNIK MICHAEL E | SVP & General Couns ... | Buy | M | 24.76 | 28,814 | 713,435 | 65,435 | 36.6 K to 65.4 K (+78.68 %) |
Aug 06 2012 | DGX | QUEST DIAGNOSTICS ... | ZIEGLER JOHN B | Director | Sell | S | 59.26 | 2,800 | 165,916 | 17,854 | 20.7 K to 17.9 K (-13.56 %) |
Jul 13 2012 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 30.46 | 20,000 | 609,100 | 0 | |
Jul 13 2012 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Option Exercise | M | 55.40 | 10,000 | 554,000 | 0 | |
Jul 13 2012 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Sell | S | 62.00 | 30,000 | 1,860,000 | 20,176 | 50.2 K to 20.2 K (-59.79 %) |
Jul 13 2012 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 30.46 | 20,000 | 609,100 | 50,176 | 30.2 K to 50.2 K (+66.28 %) |
Jul 13 2012 | DGX | QUEST DIAGNOSTICS ... | STANZIONE DANIEL | Director | Buy | M | 55.40 | 10,000 | 554,000 | 30,176 | 20.2 K to 30.2 K (+49.56 %) |
Jul 05 2012 | DGX | QUEST DIAGNOSTICS ... | RING TIMOTHY M | Director | Option Exercise | A | 60.22 | 790 | 47,570 | 790 | |
Jul 03 2012 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Option Exercise | M | 52.24 | 15,000 | 783,525 | 0 | |
Jul 03 2012 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Sell | S | 59.54 | 15,000 | 893,100 | 10,973 | 26 K to 11 K (-57.75 %) |
Jul 03 2012 | DGX | QUEST DIAGNOSTICS ... | BONGIORNO THOMAS F | VP and Corporate Co ... | Buy | M | 52.24 | 15,000 | 783,525 | 25,941 | 10.9 K to 25.9 K (+137.10 %) |
Jul 03 2012 | DGX | QUEST DIAGNOSTICS ... | ORDONEZ KATHY | SVP, Discovery & De ... | Payment of Exercise | F | 59.77 | 239 | 14,285 | 10,635 | 10.9 K to 10.6 K (-2.20 %) |